0001123292-18-000552.txt : 20180321
0001123292-18-000552.hdr.sgml : 20180321
20180321170113
ACCESSION NUMBER: 0001123292-18-000552
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180209
FILED AS OF DATE: 20180321
DATE AS OF CHANGE: 20180321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keefer Jason
CENTRAL INDEX KEY: 0001717590
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32966
FILM NUMBER: 18705039
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001360886
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 710881115
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
BUSINESS PHONE: 443-545-1819
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
3
1
edgar.xml
PRIMARY DOCUMENT
X0206
3
2018-02-09
0
0001360886
OSIRIS THERAPEUTICS, INC.
OSIR
0001717590
Keefer Jason
7015 ALBERT EINSTEIN DRIVE
COLUMBIA
MD
21046
0
1
0
0
Interim President & CEO
Incentive Stock Opton (right to buy)
6.80
2018-07-19
2027-07-18
Common Stock
16000
D
4,000 shares underlying this option shall vest on each of July 19, 2018, July 19, 2019, July 19, 2020 and July 19, 2021, subject to Reporting Person's continued service through the applicable vesting date.
/s/ Jason Keefer
2018-03-21